IVC Evidensia reported to be planning £10bn London float
IVC Evidensia is one of Europe's largest veterinary care providers.
IVC Evidensia is set to launch a London float valued up to £10bn, according to media reports.
The float, expected to be unveiled in March, could reportedly see the Nestle-backed veterinary group enter the FTSE-100 index. According to Sky News, IVC has appointed Goldman Sachs and Jeffries to work on the listing.
EQT, the Stockholm-based private equity firm which backs IVC, is also said to be assessing other options, such as a trade sale of the business or the private sale of a further stake to an external investor.
IVC Evidensia is one of Europe's largest veterinary care providers, with a network of clinics, hospitals and out-of-hours centres spanning 11 countries. The group was formed in 2017 when Independent Vet Care merged with Evidensia, a Swedish-based firm also owned by EQT.
IVC Evidensia entered into a partnership with Nestlé Purina PetCare in 2019. It currently has more than 19,000 employees.
IVC Evidensia has been contacted for comment.
Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.
